Citigroup’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.3K | Buy |
2,445
+176
| +8% | +$1.48K | ﹤0.01% | 4790 |
|
|
2025
Q4 | $16.9K | Sell |
2,269
-1,693
| -43% | -$12.2K | ﹤0.01% | 4915 |
|
|
2025
Q3 | $26.5K | Sell |
3,962
-14,761
| -79% | -$102K | ﹤0.01% | 4719 |
|
|
2025
Q2 | $124K | Sell |
18,723
-10,298
| -35% | -$73K | ﹤0.01% | 4307 |
|
|
2025
Q1 | $266K | Sell |
29,021
-2,951
| -9% | -$29.5K | ﹤0.01% | 4030 |
|
|
2024
Q4 | $336K | Buy |
31,972
+4,527
| +16% | +$53.5K | ﹤0.01% | 4085 |
|
|
2024
Q3 | $328K | Buy |
27,445
+18,923
| +222% | +$164K | ﹤0.01% | 4012 |
|
|
2024
Q2 | $49K | Sell |
8,522
-121,337
| -93% | -$666K | ﹤0.01% | 4593 |
|
|
2024
Q1 | $675K | Buy |
129,859
+5,336
| +4% | +$26.1K | ﹤0.01% | 3344 |
|
|
2023
Q4 | $656K | Buy |
124,523
+71,990
| +137% | +$285K | ﹤0.01% | 3198 |
|
|
2023
Q3 | $173K | Buy |
52,533
+52,146
| +13,474% | +$183K | ﹤0.01% | 3728 |
|
|
2023
Q2 | $1.12K | Buy |
387
+316
| +445% | +$606 | ﹤0.01% | 5328 |
|
|
2023
Q1 | $76 | Sell |
71
-911
| -93% | -$1.74K | ﹤0.01% | 5301 |
|
|
2022
Q4 | $2.56K | Sell |
982
-16,834
| -94% | -$73.5K | ﹤0.01% | 5171 |
|
|
2022
Q3 | $125K | Sell |
17,816
-1,331
| -7% | -$10.4K | ﹤0.01% | 3990 |
|
|
2022
Q2 | $131K | Buy |
19,147
+1,752
| +10% | +$17.9K | ﹤0.01% | 4069 |
|
|
2022
Q1 | $245K | Sell |
17,395
-799
| -4% | -$10.7K | ﹤0.01% | 3960 |
|
|
2021
Q4 | $264K | Sell |
18,194
-1,331
| -7% | -$18.9K | ﹤0.01% | 4191 |
|
|
2021
Q3 | $276K | Buy |
19,525
+19,130
| +4,843% | +$294K | ﹤0.01% | 3954 |
|
|
2021
Q2 | $7K | Sell |
395
-114
| -22% | -$1.84K | ﹤0.01% | 5762 |
|
|
2021
Q1 | $8K | Buy |
+509
| New | +$7.25K | ﹤0.01% | 5747 |
|
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
